Keybank National Association Teva Pharmaceutical Industries LTD Transaction History

Keybank National Association

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$16.68 - $22.07 $263,410 - $348,529	-15,792 Closed	0 $0
Q4 2017 Feb 08, 2018	SELL	$11.23 - $19.1 $172,840 - $293,968	-15,391 Reduced 49.36%	15,792 $299,000
Q3 2017 Nov 02, 2017	SELL	$15.41 - $32.17 $76,341 - $159,370	-4,954 Reduced 13.71%	31,183 $549,000
Q2 2017 May 14, 2018	SELL	N/A	-8,387 Reduced 18.84%	36,137 $1.2 Million
Q1 2017 May 14, 2018	SELL	N/A	-4,328 Reduced 8.86%	44,524 $1.43 Million
Q4 2016 May 14, 2018	BUY	N/A	48,852	48,852 $1.77 Million

624

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

Stay updated on Keybank National Association with notifications on news.